Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals | 7 | 0 | 1 | 0 | €7.30 | €11.13 | 52.540% |
| MacroGenics Inc. | 13 | 0 | 2 | 0 | €3.16 | €11.86 | 275.707% |
| Allscripts Healthcare | 2 | 0 | 0 | 0 | €8.00 | €11.95 | 49.394% |
| Phibro Animal Health Corp. A | 3 | 2 | 0 | 0 | €15.80 | €12.06 | -23.646% |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 0 | 0 | €2.30 | €12.21 | 430.909% |
| Ocular Therapeutix Inc. | 15 | 4 | 2 | 0 | €7.63 | €13.09 | 71.506% |
| Syros Pharmaceuticals Inc. | 7 | 1 | 1 | 0 | €4.70 | €13.85 | 194.606% |
| Rigel Pharmaceutical Inc. | 13 | 0 | 0 | 0 | €0.74 | €13.86 | 1772.365% |
| Verastem Inc. | 14 | 0 | 3 | 0 | €2.16 | €16.61 | 669.167% |
| R1 RCM Inc. | 23 | 0 | 0 | 0 | €12.70 | €17.21 | 35.532% |
| Amicus Therapeutics Inc. | 7 | 0 | 0 | 0 | €10.30 | €17.64 | 71.240% |
| Abeona Therapeutics Inc. | 6 | 1 | 1 | 0 | €4.06 | €19.31 | 375.603% |
| Kala Pharmaceuticals Inc. | 5 | 0 | 0 | 0 | €5.34 | €19.50 | 265.140% |
| Stoke Therapeutics Inc | 14 | 1 | 1 | 0 | €13.00 | €20.33 | 56.412% |
| Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | €1.38 | €20.55 | 1388.986% |
| Myriad Genetics | 4 | 3 | 0 | 1 | €24.00 | €22.15 | -7.719% |
| Evolus Inc | 11 | 0 | 2 | 0 | €11.70 | €22.65 | 93.622% |
| Novavax Inc. | 4 | 1 | 1 | 1 | €10.62 | €22.91 | 115.725% |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 1 | 0 | €16.76 | €24.74 | 47.598% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Enanta Pharmaceuticals Inc. | 6 | 4 | 1 | 1 | €11.20 | €25.11 | 124.172% |
| Iovance Biotherapeutics Inc. | 20 | 2 | 0 | 0 | €9.09 | €25.72 | 182.817% |
| Exelixis Inc. | 22 | 0 | 4 | 0 | €24.89 | €26.01 | 4.485% |
| Dynavax Technologies Corp | 4 | 0 | 1 | 0 | €9.80 | €26.95 | 175.053% |
| EyePoint Pharmaceuticals Inc. | 19 | 1 | 0 | 0 | €8.28 | €28.29 | 241.804% |